Wickus G G, Dukerschein R O, Pierce J R, Davis K D
Clin Chem. 1982 Oct;28(10):2131-4.
We examined the mechanism by which hypertriglyceridemia interferes with the Roche Diagnostics "Amylochrome" procedure for measurement of amylase in lactescent samples with normal and above-normal amylase activity. The serum blank recommended in the Amylochrome protocol to compensate for lactescence remains inappropriately turbid, compared with the test, and is partly responsible for the underestimation of amylase activity. Other major interference is seen when lipoprotein in hyperlipemic samples with above-normal amylase activity reacts with the soluble oligosaccharide-triazinyl dye product of the Amylochrome assay to form a flocculent blue precipitate. The formation of this precipitate in the test, and its removal, diminish lactescence due to lipemia, an effect that cannot be matched by any manipulation of a serum blank procedure. Oligosaccharide-dye product is removed as a component of the precipitate.
我们研究了高甘油三酯血症干扰罗氏诊断公司“淀粉样色素法”测定含正常及高于正常淀粉酶活性的乳状样本中淀粉酶的机制。与测试样本相比,淀粉样色素法方案中推荐用于补偿乳状现象的血清空白仍存在不适当的浑浊,这部分导致了淀粉酶活性的低估。当淀粉酶活性高于正常的高脂血症样本中的脂蛋白与淀粉样色素法测定的可溶性寡糖 - 三嗪基染料产物反应形成絮凝状蓝色沉淀时,会出现其他主要干扰。测试中这种沉淀的形成及其去除减少了因脂血症导致的乳状现象,而血清空白程序的任何操作都无法达到这种效果。寡糖 - 染料产物作为沉淀的一部分被去除。